Combination Therapy With DPP-4 Inhibitors and Pioglitazone in Type 2 Diabetes: Theoretical Consideration and Therapeutic Potential
Vascular Health and Risk Management
doi 10.2147/vhrm.s3374
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2008
Authors
Publisher
Informa UK Limited